Exclusive special offer and discount title banner vector image

GLOBAL AEROSOL DELIVERY DEVICES MARKET FORECAST 2023-2032

SCOPE OF THE REPORT

Global Aerosol Delivery Devices Market by Product (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers) Market by Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Non-respiratory Diseases) Market by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-commerce) by Geography

REQUEST FREE SAMPLE

MARKET OVERVIEW

The global aerosol delivery devices market was valued at $xx billion in 2022 and is expected to reach $xx billion by 2032, growing at a CAGR of 4.45% during the forecast period, 2023-2032.

Aerosol delivery devices are essential tools in administering medication directly into the lungs for the treatment of various respiratory conditions like asthma and COPD. They come in different forms, such as Dry Powder Inhalers (DPIs) dispersing dry powder upon inhalation, Metered Dose Inhalers (MDIs) delivering a specific dosage of medication in aerosol form, and Nebulizers transforming liquid medication into mist for inhalation via a mask or mouthpiece. Each type has its benefits, catering to different patient needs. MDIs for precise dosing, DPIs for breath-activated release, and nebulizers for individuals having difficulty with handheld devices.

Aerosol Delivery Devices Market

Read our latest blog on the Aerosol Delivery Devices Market

GROWTH ENABLERS

Key enablers of the global aerosol delivery devices market growth are:

  • Surging incidences of chronic obstructive pulmonary disease (COPD) and asthma
  • Upsurge in government programs
  • Benefits compared to traditional drug delivery devices
    • Aerosol delivery devices exhibit a range of advantages over traditional drug delivery methods. These devices offer targeted drug delivery, directing medication precisely to the lungs and leading to better therapeutic outcomes while minimizing systemic side effects.
    • Their rapid onset of action stands in contrast to traditional oral medication, providing quicker relief for respiratory conditions like asthma or COPD. Moreover, their user-friendly design, portability, and potential to enhance patient adherence make them a preferred choice, fostering improved compliance with treatment regimens.
    • Additionally, the devices allow for precise dosing, a crucial factor in managing respiratory conditions effectively, a feature that may not be as accurate in traditional delivery methods. These advantages position aerosol delivery devices as a prominent and influential force in the global market, offering significant potential for improving patient outcomes and treatment adherence.
  • Escalation of airborne pollution

GROWTH RESTRAINTS

Key growth restraining factors of the global aerosol delivery devices market are:

  • Limited access in underdeveloped nations
    • Limited access in underdeveloped nations poses a significant challenge in the global aerosol delivery devices market due to a range of factors. These nations often lack adequate healthcare infrastructure, hindering the availability and distribution of these devices, thereby restricting access to essential respiratory treatments.
    • Economic constraints also play a crucial role, as the high costs associated with aerosol delivery devices make them less accessible in underdeveloped areas, limiting the population’s ability to obtain necessary respiratory care.
    • Additionally, the lack of awareness and education about the benefits and proper use of these devices among healthcare professionals and the general public further hampers their utilization.
  • Elevated costs of asthma and COPD treatments

To Know More About This Report, Request a Free Sample Copy

KEY MARKET TRENDS

Global Aerosol Delivery Devices Market | Top Trends

  • The global aerosol delivery devices market is experiencing significant growth in connected systems, integrating technology like Bluetooth and sensors for remote monitoring. These advancements enhance patient adherence, provide real-time data, and revolutionize respiratory care on a global scale.
  • Aerosol delivery systems are increasingly diversifying into non-respiratory applications such as dermatology, vaccinations, and targeted drug delivery, reflecting a growing trend towards their versatile use across various medical and cosmetic fields.

MARKET SEGMENTATION

Market Segmentation – Product, Application, and Distribution Channel –

Market by Product:

  • Dry Powder Inhalers (DPIs)
    • Dry powder inhalers (DPIs) are witnessing the most significant growth in the global aerosol delivery devices market. These devices are designed to administer medication in dry powder form directly to the lungs. These devices function without the need for propellants or a pressurized container, relying on the patient’s inhalation to release the powdered medication.
    • DPIs come in various designs, from single-dose to multi-dose formats, offering ease of use and portability. Their breath-actuated nature makes them user-friendly and suitable for individuals with varying physical capabilities.
    • The DPIs market continues to advance with a focus on improving drug delivery efficiency, dosage accuracy, and overall patient convenience, contributing to their growing adoption in the treatment of respiratory conditions worldwide.
  • Metered Dose Inhalers (MDIs)
  • Nebulizers

Market by Application:

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis
  • Non-Respiratory Diseases
    • Diabetes
    • Analgesia
    • Parkinson’s Disease

Market by Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • E-Commerce
    • E-commerce is a rapidly expanding distribution channel for aerosol delivery devices, allowing patients to conveniently purchase them from various retailers, including major pharmacies and online platforms like Amazon.
    • This accessibility enables users to compare and buy a wide range of devices from different brands, with the added convenience of home delivery.
    • Furthermore, the detailed product information, reviews, and home delivery options provided by e-commerce greatly enhance access to respiratory treatment devices, particularly benefiting remote areas and positively impacting global respiratory condition management.

GEOGRAPHICAL STUDY

Geographical Study based on Four Major Regions:

  • North America: The United States and Canada
    • North America is anticipated to be the largest regional market in 2022, primarily driven by the high prevalence of respiratory conditions such as asthma and COPD in North America, creating a strong demand for effective treatment solutions.
    • Furthermore, both patients and healthcare professionals in North America are becoming increasingly cognizant of the advantages offered by aerosol delivery devices, including their non-invasive administration, user-friendliness, and precision in delivering targeted treatments. This growing awareness is projected to sustain the expansion of the aerosol delivery devices market in North America.
  • Europe: The United Kingdom, Germany, France, Italy, Spain, Belgium, Poland, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
  • Rest of World: Latin America, Middle East & Africa

MAJOR PLAYERS

The major players in the global aerosol delivery devices market are:

  • 3M Company
  • GSK plc
  • Iconovo AB
  • Koninklijke Philips NV
  • Merck & Co Inc
  • Teva Pharmaceutical Industries Ltd
  • The Heitkamp & Thumann Group (Presspart Verwaltungs GmbH)

Key strategies adopted by some of these companies:

  • In May 2023, Flexicare acquired Clement Clarke International (CCI), a medical device manufacturer based in the United Kingdom.
  • In July 2022, Transpire Bio, a pharmaceutical company specializing in inhaled therapeutics, partnered with Recipharm to develop TRB-1 and TRB-2, inhaled treatments for asthma and COPD. This strategic move signifies a development in the aerosol delivery devices market, focusing on advancing respiratory condition treatments.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Billion)
Segments AnalyzedProduct, Application, Distribution Channel
Geographies AnalyzedNorth America, Europe, Asia-Pacific, and Rest of World
Companies Analyzed

3M Company, Aerogen, Flexicare Medical Ltd, Gerresheimer AG, GSK plc, Iconovo AB, Koninklijke Philips NV, Merck & Co Inc, Merxin Ltd, Nemera, Recipharm AB, Teva Pharmaceutical Industries Ltd, The Heitkamp & Thumann Group (Presspart Verwaltungs GmbH), Vectura Group Ltd

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
    5. MAJOR MARKET FINDINGS
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. SURGING INCIDENCES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA
      2. UPSURGE IN GOVERNMENT PROGRAMS
      3. BENEFITS COMPARED TO TRADITIONAL DRUG DELIVERY DEVICES
      4. ESCALATION OF AIRBORNE POLLUTION
    2. KEY RESTRAINTS
      1. LIMITED ACCESS IN UNDERDEVELOPED NATIONS
      2. ELEVATED COSTS OF ASTHMA AND COPD TREATMENTS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
    4. MARKET MATURITY ANALYSIS
    5. MARKET CONCENTRATION ANALYSIS
  5. MARKET BY PRODUCT
    1. DRY POWDER INHALERS (DPIS)
    2. METERED DOSE INHALERS (MDIS)
    3. NEBULIZERS
  6. MARKET BY APPLICATION
    1. ASTHMA
    2. CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    3. CYSTIC FIBROSIS
    4. NON-RESPIRATORY DISEASES
      1. DIABETES
      2. ANALGESIA
      3. PARKINSON’S DISEASE
  7. MARKET BY DISTRIBUTION CHANNEL
    1. RETAIL PHARMACIES
    2. HOSPITAL PHARMACIES
    3. E-COMMERCE
  8. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET DRIVERS
      3. NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET CHALLENGES
      4. KEY PLAYERS IN NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET
      5. COUNTRY ANALYSIS
        1. UNITED STATES
          1. UNITED STATES AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        2. CANADA
          1. CANADA AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. EUROPE AEROSOL DELIVERY DEVICES MARKET DRIVERS
      3. EUROPE AEROSOL DELIVERY DEVICES MARKET CHALLENGES
      4. KEY PLAYERS IN EUROPE AEROSOL DELIVERY DEVICES MARKET
      5. COUNTRY ANALYSIS
        1. UNITED KINGDOM
          1. UNITED KINGDOM AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        2. GERMANY
          1. GERMANY AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        3. FRANCE
          1. FRANCE AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        4. ITALY
          1. ITALY AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        5. SPAIN
          1. SPAIN AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        6. BELGIUM
          1. BELGIUM AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        7. POLAND
          1. POLAND AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        8. REST OF EUROPE
          1. REST OF EUROPE AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
    3. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET DRIVERS
      3. ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET CHALLENGES
      4. KEY PLAYERS IN ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET
      5. COUNTRY ANALYSIS
        1. CHINA
          1. CHINA AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        2. JAPAN
          1. JAPAN AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        3. INDIA
          1. INDIA AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        4. SOUTH KOREA
          1. SOUTH KOREA AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        5. INDONESIA
          1. INDONESIA AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        6. THAILAND
          1. THAILAND AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        7. VIETNAM
          1. VIETNAM AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        8. AUSTRALIA & NEW ZEALAND
          1. AUSTRALIA & NEW ZEALAND AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        9. REST OF ASIA-PACIFIC
          1. REST OF ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. REST OF WORLD AEROSOL DELIVERY DEVICES MARKET DRIVERS
      3. REST OF WORLD AEROSOL DELIVERY DEVICES MARKET CHALLENGES
      4. KEY PLAYERS IN REST OF WORLD AEROSOL DELIVERY DEVICES MARKET
      5. REGIONAL ANALYSIS
        1. LATIN AMERICA
          1. LATIN AMERICA AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
        2. MIDDLE EAST & AFRICA
          1. MIDDLE EAST & AFRICA AEROSOL DELIVERY DEVICES MARKET SIZE & OPPORTUNITIES
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PARTNERSHIPS & AGREEMENTS
      3. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. 3M COMPANY
        1. COMPANY OVERVIEW
        2. PRODUCTS
        3. STRENGTHS & CHALLENGES
      2. AEROGEN
        1. COMPANY OVERVIEW
        2. PRODUCTS
        3. STRENGTHS & CHALLENGES
      3. FLEXICARE MEDICAL LTD
        1. COMPANY OVERVIEW
        2. PRODUCTS
        3. STRENGTHS & CHALLENGES
      4. GERRESHEIMER AG
        1. COMPANY OVERVIEW
        2. PRODUCTS
        3. STRENGTHS & CHALLENGES
      5. GSK PLC
        1. COMPANY OVERVIEW
        2. PRODUCTS
        3. STRENGTHS & CHALLENGES
      6. ICONOVO AB
        1. COMPANY OVERVIEW
        2. PRODUCTS
        3. STRENGTHS & CHALLENGES
      7. KONINKLIJKE PHILIPS NV
        1. COMPANY OVERVIEW
        2. PRODUCTS
        3. STRENGTHS & CHALLENGES
      8. MERCK & CO INC
        1. COMPANY OVERVIEW
        2. PRODUCTS
        3. STRENGTHS & CHALLENGES
      9. MERXIN LTD
        1. COMPANY OVERVIEW
        2. PRODUCTS
        3. STRENGTHS & CHALLENGES
      10. NEMERA
        1. COMPANY OVERVIEW
        2. PRODUCTS
        3. STRENGTHS & CHALLENGES
      11. RECIPHARM AB
        1. COMPANY OVERVIEW
        2. PRODUCTS
        3. STRENGTHS & CHALLENGES
      12. TEVA PHARMACEUTICAL INDUSTRIES LTD
        1. COMPANY OVERVIEW
        2. PRODUCTS
        3. STRENGTHS & CHALLENGES
      13. THE HEITKAMP & THUMANN GROUP (PRESSPART VERWALTUNGS GMBH)
        1. COMPANY OVERVIEW
        2. PRODUCTS
        3. STRENGTHS & CHALLENGES
      14. VECTURA GROUP LTD
        1. COMPANY OVERVIEW
        2. PRODUCTS
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – AEROSOL DELIVERY DEVICES

TABLE 2: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 3: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 4: GLOBAL DRY POWDER INHALERS (DPIS) MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 5: GLOBAL DRY POWDER INHALERS (DPIS) MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 6: GLOBAL METERED DOSE INHALERS (MDIS) MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 7: GLOBAL METERED DOSE INHALERS (MDIS) MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 8: GLOBAL NEBULIZERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 9: GLOBAL NEBULIZERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 10: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 11: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 12: GLOBAL ASTHMA MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 13: GLOBAL ASTHMA MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 14: GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 15: GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 16: GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 17: GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 18: GLOBAL NON-RESPIRATORY DISEASES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 19: GLOBAL NON-RESPIRATORY DISEASES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 20: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY NON-RESPIRATORY DISEASES, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 21: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY NON-RESPIRATORY DISEASES, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 22: GLOBAL DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 23: GLOBAL DIABETES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 24: GLOBAL ANALGESIA MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 25: GLOBAL ANALGESIA MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 26: GLOBAL PARKINSON’S DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 27: GLOBAL PARKINSON’S DISEASE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 28: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 29: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 30: GLOBAL RETAIL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 31: GLOBAL RETAIL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 32: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 33: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 34: GLOBAL E-COMMERCE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 35: GLOBAL E-COMMERCE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 36: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 37: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 38: NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 39: NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 40: KEY PLAYERS OPERATING IN NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET

TABLE 41: EUROPE AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 42: EUROPE AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 43: KEY PLAYERS OPERATING IN EUROPE AEROSOL DELIVERY DEVICES MARKET

TABLE 44: ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 45: ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 46: KEY PLAYERS OPERATING IN ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET

TABLE 47: REST OF WORLD AEROSOL DELIVERY DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ BILLION)

TABLE 48: REST OF WORLD AEROSOL DELIVERY DEVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ BILLION)

TABLE 49: KEY PLAYERS OPERATING IN REST OF WORLD AEROSOL DELIVERY DEVICES MARKET

TABLE 50: LIST OF MERGERS & ACQUISITIONS

TABLE 51: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 52: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR THE UNITED STATES

FIGURE 4: GROWTH PROSPECT MAPPING FOR GERMANY

FIGURE 5: GROWTH PROSPECT MAPPING FOR JAPAN

FIGURE 6: GROWTH PROSPECT MAPPING FOR BRAZIL

FIGURE 7: MARKET MATURITY ANALYSIS

FIGURE 8: MARKET CONCENTRATION ANALYSIS

FIGURE 9: GLOBAL AEROSOL DELIVERY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2022

FIGURE 10: GLOBAL AEROSOL DELIVERY DEVICES MARKET, DRY POWDER INHALERS (DPIS), 2023-2032 (IN $ BILLION)

FIGURE 11: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY METERED DOSE INHALERS (MDIS), 2023-2032 (IN $ BILLION)

FIGURE 12: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY NEBULIZERS, 2023-2032 (IN $ BILLION)

FIGURE 13: GLOBAL AEROSOL DELIVERY DEVICES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022

FIGURE 14: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY ASTHMA, 2023-2032 (IN $ BILLION)

FIGURE 15: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2023-2032 (IN $ BILLION)

FIGURE 16: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY CYSTIC FIBROSIS, 2023-2032 (IN $ BILLION)

FIGURE 17: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY NON-RESPIRATORY DISEASES, 2023-2032 (IN $ BILLION)

FIGURE 18: GLOBAL AEROSOL DELIVERY DEVICES MARKET, GROWTH POTENTIAL, BY NON-RESPIRATORY DISEASES, IN 2022

FIGURE 19: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY DIABETES, 2023-2032 (IN $ BILLION)

FIGURE 20: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY ANALGESIA, 2023-2032 (IN $ BILLION)

FIGURE 21: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY PARKINSON’S DISEASE, 2023-2032 (IN $ BILLION)

FIGURE 22: GLOBAL AEROSOL DELIVERY DEVICES MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNEL, IN 2022

FIGURE 23: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY RETAIL PHARMACIES, 2023-2032 (IN $ BILLION)

FIGURE 24: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY HOSPITAL PHARMACIES, 2023-2032 (IN $ BILLION)

FIGURE 25: GLOBAL AEROSOL DELIVERY DEVICES MARKET, BY E-COMMERCE, 2023-2032 (IN $ BILLION)

FIGURE 26: NORTH AMERICA AEROSOL DELIVERY DEVICES MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 27: UNITED STATES AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 28: CANADA AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 29: EUROPE AEROSOL DELIVERY DEVICES MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 30: UNITED KINGDOM AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 31: GERMANY AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 32: FRANCE AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 33: ITALY AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 34: SPAIN AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 35: BELGIUM AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 36: POLAND AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 37: REST OF EUROPE AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 38: ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN%)

FIGURE 39: CHINA AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 40: JAPAN AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 41: INDIA AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 42: SOUTH KOREA AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 43: INDONESIA AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 44: THAILAND AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 45: VIETNAM AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 46: AUSTRALIA & NEW ZEALAND AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 47: REST OF ASIA-PACIFIC AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 48: REST OF WORLD AEROSOL DELIVERY DEVICES MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)

FIGURE 49: LATIN AMERICA AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FIGURE 50: MIDDLE EAST & AFRICA AEROSOL DELIVERY DEVICES MARKET, 2023-2032 (IN $ BILLION)

FAQ’s

FAQs

A: Non-respiratory diseases are the fastest-growing application in the global aerosol delivery devices market.

A: Aerosol delivery devices allow targeted delivery of medication directly to the lungs, leading to faster and more effective relief for respiratory conditions while minimizing systemic side effects.

Request Customization
Request Customization